One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan

Core Insights - Zuckerman Investment Group has increased its stake in Henry Schein by purchasing an additional 72,040 shares, raising its total position to 281,339 shares valued at $18.67 million as of September 30 [2][3] - The purchase reflects a strategic move by the fund, which focuses on capital-efficient, cash-generating businesses, and aligns with Henry Schein's improving earnings profile and aggressive stock buybacks [10][12] Company Overview - Henry Schein, Inc. is a leading global distributor of healthcare products and services, primarily in the dental and medical markets, leveraging a vast distribution network and technology-enabled services [6][9] - The company reported a trailing twelve months (TTM) revenue of $12.94 billion and a net income of $391 million [4] Financial Performance - In the third quarter, Henry Schein's revenue increased by 5% to $3.3 billion, with adjusted EBITDA rising to $295 million and non-GAAP EPS increasing by 13% year over year to $1.38 [10] - Management has raised its full-year non-GAAP EPS guidance to a range of $4.88 to $4.96 and lifted its sales growth outlook to 3% to 4% [10] Market Position - As of the latest trading, Henry Schein's shares were priced at $76.33, reflecting an 8% increase over the past year, although this performance lags behind the S&P 500, which has risen by approximately 15.5% in the same period [3] - The company's stock buyback program included $229 million in repurchases during the quarter, with an additional $980 million authorized for future buybacks [12] Growth Initiatives - Henry Schein's global technology sales grew nearly 10%, and specialty products increased close to 6%, with management expecting over $200 million in operating income improvement from value creation initiatives in the coming years [11]